Deborah C. Lambkin

Array ( [id] => 377119 [patent_doc_number] => 07312219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Heteroaromatic inhibitors of fructose 1,6-bisphosphatase' [patent_app_type] => utility [patent_app_number] => 10/636474 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 133981 [patent_no_of_claims] => 145 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312219.pdf [firstpage_image] =>[orig_patent_app_number] => 10636474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 985558 [patent_doc_number] => 06924286 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 10/633376 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40526 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924286.pdf [firstpage_image] =>[orig_patent_app_number] => 10633376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972265 [patent_doc_number] => 20050037975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Method for treatment of glutamate related disorders' [patent_app_type] => utility [patent_app_number] => 10/626923 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9827 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037975.pdf [firstpage_image] =>[orig_patent_app_number] => 10626923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 756580 [patent_doc_number] => 07019453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Polymers having pendant nonlinear optical chromophores and electro-optic devices therefrom' [patent_app_type] => utility [patent_app_number] => 10/625371 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6946 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019453.pdf [firstpage_image] =>[orig_patent_app_number] => 10625371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913213 [patent_doc_number] => 20050176971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Method for producing 2-alkyl-3-aminothiophene derivative' [patent_app_type] => utility [patent_app_number] => 10/517494 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7435 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176971.pdf [firstpage_image] =>[orig_patent_app_number] => 10517494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7619994 [patent_doc_number] => 06943189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/620460 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60793 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 1192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943189.pdf [firstpage_image] =>[orig_patent_app_number] => 10620460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475065 [patent_doc_number] => 20040097570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds' [patent_app_type] => new [patent_app_number] => 10/618727 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23839 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097570.pdf [firstpage_image] =>[orig_patent_app_number] => 10618727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368220 [patent_doc_number] => 20040092552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => '2-Fluorobenzenesulfonyl compounds for the treatment of inflammation' [patent_app_type] => new [patent_app_number] => 10/258493 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45149 [patent_no_of_claims] => 113 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092552.pdf [firstpage_image] =>[orig_patent_app_number] => 10258493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674413 [patent_doc_number] => 20040127705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action' [patent_app_type] => new [patent_app_number] => 10/615836 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13313 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127705.pdf [firstpage_image] =>[orig_patent_app_number] => 10615836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469984 [patent_doc_number] => 20040054195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Xanthene derivatives' [patent_app_type] => new [patent_app_number] => 10/250975 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5303 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054195.pdf [firstpage_image] =>[orig_patent_app_number] => 10250975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674413 [patent_doc_number] => 20040127705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action' [patent_app_type] => new [patent_app_number] => 10/615836 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13313 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127705.pdf [firstpage_image] =>[orig_patent_app_number] => 10615836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363602 [patent_doc_number] => 20040014968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Heteroaromatic glucokinase activators' [patent_app_type] => new [patent_app_number] => 10/616359 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94049 [patent_no_of_claims] => 278 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014968.pdf [firstpage_image] =>[orig_patent_app_number] => 10616359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401215 [patent_doc_number] => 20040019018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Rigid pyrrolidone modulators of pkc' [patent_app_type] => new [patent_app_number] => 10/258661 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18032 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019018.pdf [firstpage_image] =>[orig_patent_app_number] => 10258661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951463 [patent_doc_number] => 06960668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Process for the production of substituted thioxanthones' [patent_app_type] => utility [patent_app_number] => 10/613303 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2103 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960668.pdf [firstpage_image] =>[orig_patent_app_number] => 10613303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207710 [patent_doc_number] => 20040087620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Terphenyl compounds bearing substituted amino groups' [patent_app_type] => new [patent_app_number] => 10/250583 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65417 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087620.pdf [firstpage_image] =>[orig_patent_app_number] => 10250583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 733128 [patent_doc_number] => 07037931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'CCK-1 receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/612150 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78481 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037931.pdf [firstpage_image] =>[orig_patent_app_number] => 10612150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453777 [patent_doc_number] => 20040100188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Anthracene derivative and organic electroluminescence device using the derivative' [patent_app_type] => new [patent_app_number] => 10/610930 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15540 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20040100188.pdf [firstpage_image] =>[orig_patent_app_number] => 10610930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 979102 [patent_doc_number] => 06930106 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-16 [patent_title] => 'Inhibitors of HCV NS5B polymerase' [patent_app_type] => utility [patent_app_number] => 10/610096 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9926 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/930/06930106.pdf [firstpage_image] =>[orig_patent_app_number] => 10610096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 754714 [patent_doc_number] => 07019023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-28 [patent_title] => 'Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use' [patent_app_type] => utility [patent_app_number] => 10/606771 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3999 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/019/07019023.pdf [firstpage_image] =>[orig_patent_app_number] => 10606771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 711241 [patent_doc_number] => 07056947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Aza-peptide epoxides' [patent_app_type] => utility [patent_app_number] => 10/603054 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46717 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056947.pdf [firstpage_image] =>[orig_patent_app_number] => 10603054 [rel_patent_id] =>[rel_patent_doc_number] =>)